◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

浩欧博

浩欧博
Loading...
Key Metrics
Market Cap
8.5B ($1.2B)
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
398.0M
Net Income
23.2M
Gross Margin
N/A
Op. Margin
6.7%
Net Margin
5.8%
ROE
2.8%
ROA
2.5%
D/E
0.14
Dividend Yield
N/A
EPS
0.37
Current Ratio
2.17
Price History
Company Info
IndustryC27医药制造业
Market SegmentSTAR Market
CurrencyCNY
Fiscal Year2025
Business Overview

HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. The company was founded in 2009 and is based in Suzhou, China.

Peers
工商银行
601398
2.7T
P/E: 7.6
建设银行
601939
2.5T
P/E: 7.2
农业银行
601288
2.4T
P/E: 8.7
中国海油
600938
2.0T
P/E: 16.2
宁德时代
300750
1.9T
P/E: 25.6
贵州茅台
600519
1.8T
P/E: 20.1
中国银行
601988
1.8T
P/E: 7.3
中国人寿
601628
1.2T
P/E: 6.9
Financial Statements
Loading financials...
Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 浩欧博

HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. The company was founded in 2009 and is based in Suzhou, China.


Ticker688656
ExchangeSSE
Sector证监会行业分类
IndustryC27医药制造业
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...